Breaking News Instant updates and real-time market news.

AGTC

Applied Genetic

$2.75

0.005 (0.18%)

16:37
12/02/19
12/02
16:37
12/02/19
16:37

Applied Genetic Chief Medical Officer to step down

Applied Genetic Technologies announced that Theresa Heah, M.D., Chief Medical Officer, has resigned from the company to pursue other opportunities. Given that the clinical results for the upcoming data releases are still being processed at external vendors and not yet available for internal review, Dr. Heah's resignation does not relate to any knowledge of pending results. Dr. Heah has agreed to stay with the company until the end of the year to support the up-coming data analysis. In addition, Dr. Heah's departure does not affect the company's previously announced guidance on the timing of data reporting from its ongoing Phase 1/2 clinical trials in patients with X-linked retinitis pigmentosa and achromatopsia.

  • 04

    Dec

AGTC Applied Genetic
$2.75

0.005 (0.18%)

09/27/19
BMOC
09/27/19
UPGRADE
Target $9
BMOC
Outperform
Applied Genetic upgraded to Outperform from Market Perform at BMO Capital
BMO Capital analyst Matthew Luchini upgraded Applied Genetic Technologies to Outperform from Market Perform and raised his price target for the shares to $9 from $5. The early XLRP data suggest potential for vision stabilization in peripherally treated patients and vision improvement in centrally treated patients, Luchini tells investors in a research note. He believes these early results provide preliminary proof-of-concept and support his higher estimated probability of success of 25% on $410M unadjusted peak sales. The analyst sees a favorable risk/reward on Applied Genetic shares.
09/27/19
HCWC
09/27/19
NO CHANGE
Target $18
HCWC
Buy
Applied Genetic price target raised to $18 from $12 at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis raised his price target for Applied Genetic Technologies to $18 from $12 saying new clinical data updates puts the company "squarely back in the gene therapy mix." The analyst expects revaluation of the shares based on the clinical data presented and more upcoming data. He keeps a Buy rating on Applied Genetic.
09/27/19
09/27/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Western Union (WU) upgraded to Buy from Neutral at Guggenheim with analyst Jeff Cantwell citing what he called the company's "positive" investor day where management outlined "a solid 3-year growth trajectory." 2. Applied Genetic (AGTC) upgraded to Outperform from Market Perform at BMO Capital with analyst Matthew Luchini saying the early XLRP data suggest potential for vision stabilization in peripherally treated patients and vision improvement in centrally treated patients. 3. Seattle Genetics (SGEN) upgraded to Buy from Neutral at Goldman Sachs with analyst Salveen Richter saying with continued Adcetris growth in Hodgkin's lymphoma and peripheral T cell lymphoma, he expects "multiple near-term pipeline drivers to cement" the company's transition into a multi-product oncology company. 4. Match Group (MTCH) upgraded to Outperform from In Line at Evercore ISI. 5. Texas Instruments (TXN) upgraded to Buy from Neutral at BofA/Merrill with analyst Vivek Arya saying he is positive on Texas Instruments' market share gains, stronger free cash flow returns, stronger positioning in growth areas such as 5G, Internet-of-Things, and Electric vehicles. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/14/19
ROTH
10/14/19
NO CHANGE
ROTH
Ophthalmic therapies 'could go from 0 to 100 real quick,' says Roth Capital
Commenting on the Ophthalmology space, Roth Capital analyst Zegbeh Jallah highlights her conviction for stronger valuations, driven by the increasing number of companies with innovative pipelines, and pending changes at both the FDA and CMS. The analyst suspects that these changes could lead to more wins in the space, which could drive valuations. Further, she cautions investors to keep "their eyes peeled on developments in the space." Jallah sees this as possible relevant for KalVista (KALV), Regenxbio (RGNX), Kala Pharmaceuticals (KALA), Kodiak Sciences (KOD), Regeneron (REGN), Aerie Pharmaceuticals (AERI), Applied Genetic (AGTC), Aldeyra (ALDX), Adverum Biotechnologies (ADVM), Clearside Biomedical (CLSD), Ocugen (OCGN), and many others.

TODAY'S FREE FLY STORIES

MCK

McKesson

$140.56

-3.44 (-2.39%)

16:21
12/13/19
12/13
16:21
12/13/19
16:21
Conference/Events
McKessonto hold a sell-side analyst meeting »

Sell-Side Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

MDR

McDermott

$0.82

0.0412 (5.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Hot Stocks
McDermott discloses NYSE delisting notice »

McDermott announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$114.26

-1.52 (-1.31%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Conference/Events
Intercept to hold a meeting for investors »

Management holds NASH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 26

    Mar

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/13/19
12/13
16:20
12/13/19
16:20
Options
Closing CBOE SPX and VIX Index summary for December 13th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPWR

Ideal Power

$2.45

0.04 (1.66%)

16:19
12/13/19
12/13
16:19
12/13/19
16:19
Syndicate
Breaking Syndicate news story on Ideal Power »

Ideal Power files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERIE

Erie Indemnity

$168.97

0.25 (0.15%)

16:18
12/13/19
12/13
16:18
12/13/19
16:18
Hot Stocks
Erie Indemnity increases quarterly dividend »

The board of Erie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

ESRT

Empire State Realty

$13.68

0.055 (0.40%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Hot Stocks
Empire State Realty renews $500M stock repurchase program »

Empire State Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPS Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HST

Host Hotels

$17.95

0.09 (0.50%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Hot Stocks
Host Hotels declares special dividend of 5c per share »

Host Hotels & Resorts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
12/13/19
12/13
16:17
12/13/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
12/13/19
12/13
16:16
12/13/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PACW

PacWest Bancorp

$38.11

-0.54 (-1.40%)

16:14
12/13/19
12/13
16:14
12/13/19
16:14
Hot Stocks
PacWest Bancorp CEO buys 6.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$114.03

-1.75 (-1.51%)

16:13
12/13/19
12/13
16:13
12/13/19
16:13
Conference/Events
Intercept to hold a meeting for investors »

Management holds NASH…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

OC

Owens Corning

$64.62

-1.03 (-1.57%)

16:13
12/13/19
12/13
16:13
12/13/19
16:13
Hot Stocks
Owens Corning exec chairman Thaman sells 30,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRR

Carbo Ceramics

$0.42

0.0132 (3.21%)

16:11
12/13/19
12/13
16:11
12/13/19
16:11
Hot Stocks
Carbo Ceramics to delist from NYSE, applies to list on OTCQB market »

CARBO Ceramics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$0.79

-0.0009 (-0.11%)

16:07
12/13/19
12/13
16:07
12/13/19
16:07
Hot Stocks
Chesapeake receives continued listing notice from NYSE »

Chesapeake Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCVL

Shoe Carnival

$36.15

-1.43 (-3.81%)

16:06
12/13/19
12/13
16:06
12/13/19
16:06
Hot Stocks
Shoe Carnival announces new $50M share repurchase program »

Shoe Carnival announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$0.91

0.0192 (2.15%)

16:05
12/13/19
12/13
16:05
12/13/19
16:05
Hot Stocks
22nd Century CEO Cliff Fleet to step down »

22nd Century announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

16:03
12/13/19
12/13
16:03
12/13/19
16:03
Hot Stocks
Horizon Pharma: FDA committee votes unanimously to support use of teprotumumab »

Horizon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

MUX

McEwen Mining

$1.11

0.03 (2.79%)

16:03
12/13/19
12/13
16:03
12/13/19
16:03
Conference/Events
McEwen Mining to host conference call »

Chief Owenr McEwen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

PJC

Piper Jaffray

$81.49

0.13 (0.16%)

16:00
12/13/19
12/13
16:00
12/13/19
16:00
Hot Stocks
Piper Jaffray announces ticker symbol change to PIPR »

Piper Jaffray Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$357.90

-1.8 (-0.50%)

15:56
12/13/19
12/13
15:56
12/13/19
15:56
Periodicals
NHTSA to probe December 7 crash of Tesla Model 3, Reuters reports »

The U.S. National Highway…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 23

    Mar

TME

Tencent Music

$11.46

-0.54 (-4.50%)

15:55
12/13/19
12/13
15:55
12/13/19
15:55
Options
Tencent put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAYF

Hudson's Bay

$0.00

(0.00%)

15:46
12/13/19
12/13
15:46
12/13/19
15:46
Periodicals
Hudson's Bay take-private deal fails to secure investor support, Reuters says »

Hudson's Bay has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAYF

Hudson's Bay

$0.00

(0.00%)

15:43
12/13/19
12/13
15:43
12/13/19
15:43
Periodicals
Breaking Periodicals news story on Hudson's Bay »

Hudson's Bay group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.